Drug Approval | March 29, 2023
Zydus receives final approval from USFDA for Loperamide Hydrochloride Capsules
Loperamide Hydrochloride Capsules USP, 2 mg had annual sales of US $34.7 million in the United States
Loperamide Hydrochloride Capsules USP, 2 mg had annual sales of US $34.7 million in the United States
Pre-filled pens containing a combination of insulin glargine 100 Units/mL and lixisenatide for once-daily dosing
hubergroup’s two newly added medical vans are dedicated to dental and eye care
Women of all ages will get round-the-clock access to comprehensive treatment
ZYIL1 is a novel oral small molecule NLRP3 inhibitor which has demonstrated CSF penetration in non-human primates
Rocuronium Bromide Injection had an annual sale of approximately US $53 million in the US (IQVIA MAT December 2022)
The antiviral is efficacious in non-human primates, and is safe and well-tolerated in humans
Subgroup analysis by HER2 expression from phase 1/2 trial of patients with HER3 expressing metastatic breast cancer highlighted in a second Presidential Session
The observations are procedural in nature
He is Proficient in overseeing and leading teams for running successful business operations
Subscribe To Our Newsletter & Stay Updated
